Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ceftazidime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD
- Strength
- 250 mg
- Dosage form
- IM injection
- Pack
- 1's
- Registration no.
- 087242
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Evolution Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Zibac 250 mg IM injection
Zibac 250 mg IM injection contains Ceftazidime 250 mg. It is registered with DRAP by Evolution Pharmaceuticals (Pvt.) Ltd (registration no. 087242). Its official price is PKR 154.79 for a pack of 1's. This price has applied since 29 July 2026. Zibac is also available as 1 g injection and 250 mg injection. No other brand of Ceftazidime 250 mg in this form is listed in Pakistan.
Other strengths of Zibac
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 154.79, effective 29 Jul 2026.
Cite this price history
MedInfoBase. Zibac 250 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/zibac-250-mg-087242-1s-evolution-pharmaceuticals-pvt-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 154.79 | 2026-07-29 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 087242Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.
